Alvarez Gemma, Molina Marta, Castilla José A, Clavero Ana, Gonzalvo María C, Sampedro Antonio, Bernat Nuria, Caba Octavio
Unidad de Gestión Clínica Laboratorios, Hospital Universitario Virgen de las Nieves, Granada, Spain; Instituto de investigación biosanitaria ibs.GRANADA, Granada, Spain.
Unidad de Gestión Clínica Laboratorios, Hospital Universitario Virgen de las Nieves, Granada, Spain; Instituto de investigación biosanitaria ibs.GRANADA, Granada, Spain; Unidad de Reproducción, Unidad de Gestión Clínica Obstetricia y Ginecología, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Reprod Biomed Online. 2023 Dec;47(6):103321. doi: 10.1016/j.rbmo.2023.103321. Epub 2023 Jul 30.
Is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present in semen samples from asymptomatic donors who have positive virus results from nasopharyngeal swabs?
Nasopharyngeal PCR was performed on 1943 sperm donors between January 2021 and March 2022. The result was positive for 140 donations, and the presence of SARS-CoV-2 could be studied in cryopreserved semen from 84 of these donors. This included 67 participants in whom the quality of fresh semen could be compared with the previous donation, the day of the PCR-positive nasopharyngeal sampling and the first subsequent donation. Semen donations were cryopreserved following total semen (n = 26) or ready-to-use (n = 58) protocols. The presence of SARS-CoV-2 in cryopreserved samples was determined by reverse transcription PCR. Semen quality (volume, concentration and progressive motility) was evaluated in accordance with World Health Organization 2010 recommendations.
SARS-CoV-2 virus was not detected in any cryopreserved total semen or ready-to-use samples. No significant differences in semen volume, concentration or progressive motility were observed between the last previous donation, the day of the positive PCR nasopharyngeal sampling and the first subsequent donation.
The lack of detection of SARS-CoV-2 in semen samples from asymptomatic individuals infected with SARS-CoV-2 supports the safety of assisted human reproduction treatments using this type of sample.
在鼻咽拭子病毒检测呈阳性的无症状捐献者的精液样本中是否存在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)?
对2021年1月至2022年3月期间的1943名精子捐献者进行了鼻咽PCR检测。140份捐献样本结果呈阳性,其中84名捐献者的冷冻精液可用于研究SARS-CoV-2的存在情况。这包括67名参与者,可将其新鲜精液质量与上次捐献、PCR阳性鼻咽采样当天以及随后的首次捐献进行比较。精液捐献按照全精液(n = 26)或即用型(n = 58)方案进行冷冻保存。通过逆转录PCR测定冷冻样本中SARS-CoV-2的存在情况。根据世界卫生组织2010年的建议评估精液质量(体积、浓度和前向运动率)。
在任何冷冻保存的全精液或即用型样本中均未检测到SARS-CoV-2病毒。在上次捐献、PCR阳性鼻咽采样当天以及随后的首次捐献之间,精液体积、浓度或前向运动率均未观察到显著差异。
在感染SARS-CoV-2的无症状个体的精液样本中未检测到SARS-CoV-2,这支持了使用此类样本进行辅助人类生殖治疗的安全性。